Concepedia

J. G. Berdeja

JG

Statistics

Publications

3

Citations

103

H-Index

3

Active since

2011

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

J. G. Berdeja is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in hematology, oncology, and radiation oncology.

Top concepts

Publications per year

2011–2021

3

Publications

3

Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms

J. G. Berdeja, Francesca Palandri, Maria R. Baer et al. · Leukemia Research · 2018 · 47 citations

, , +7

Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM).

J. G. Berdeja, Sikander Ailawadhi, Steven Weitman et al. · Journal of Clinical Oncology · 2011 · 36 citations

, , +17

UPDATED RESULTS FROM THE CARTITUDE-1 STUDY OF CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

S.Z. Usmani, J. G. Berdeja, Andrzej Jakubowiak et al. · Hematology Transfusion and Cell Therapy · 2021 · 20 citations · Full text

, , +17

1–3 of 3